TOPICAL EFLORNITHINE TREATMENT FOR HIRSUTISM IN WOMEN: SUMMARY OF FINDINGS
Open Access
- 26 May 2026
- journal article
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (2(50))
Abstract
Introduction: Hirsutism impacts 5–10% of women of reproductive age, characterized by excessive male-pattern terminal hair growth. Excess facial hair is notably distressing given its visibility, commonly diminishing women's perceptions of femininity. Evidence from clinical studies reveals that eflornithine attenuates facial hair proliferation and conspicuousness, thereby ameliorating quality of life. Aim of the study: This study aims to provide a comprehensive analysis of the scientific evidence on the effectiveness of topical eflornithine preparations in the treatment of hirsutism in women. The analysis focused specifically on monotherapy with eflornithine or in combination with other therapies such as laser and intense pulsed light treatments. Pharmacokinetics and safety of use were also evaluated. The data collected were synthesized descriptively to support a comparative assessment of different eflornithine-based treatment strategies. Material and method: This study used a systematic literature review methodology to synthesize the scientific evidence on the efficacy of topical eflornithine in the treatment of hirsutism in women. The literature review was compiled using the PubMed and Google Scholar platforms, including articles published between 2001 and 2006. Results: Topical eflornithine emerges as an efficacious intervention for hirsutism in women, demonstrating superior clinical outcomes whether employed as monotherapy or adjunctively with laser or IPL therapies.Keywords
This publication has 14 references indexed in Scilit:
- Adjuvant eflornithine to maintain IPL‐induced hair reduction in women with facial hirsutism: a randomized controlled trialJournal of the European Academy of Dermatology and Venereology, 2015
- Interventions for hirsutism (excluding laser and photoepilation therapy alone)Cochrane Database of Systematic Reviews, 2015
- Best Practice Options for Hair Removal in Patients with Unwanted Facial Hair Using Combination Therapy with Laser: Guidelines Drawn up by an Expert Working GroupDermatology, 2010
- Medical treatment of hirsutismDermatologic Therapy, 2008
- The effect of eflornithine 13.9% cream on the bother and discomfort due to hirsutism*International Journal of Dermatology, 2007
- A randomized bilateral vehicle-controlled study of eflornithine cream combined with laser treatment versus laser treatment alone for facial hirsutism in womenJournal of the American Academy of Dermatology, 2007
- Randomized, double‐blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hairInternational Journal of Dermatology, 2007
- Eflornithine Cream Combined with Laser Therapy in the Management of Unwanted Facial Hair Growth in Women: A Randomized TrialDermatologic Surgery, 2006
- Percutaneous Absorption and Pharmacokinetics of Eflornithine HCl 13.9% Cream in Women with Unwanted Facial HairThe Journal of Clinical Pharmacology, 2001
- Human Dermal Safety Studies with Eflornithine HCl 13.9% Cream (Vaniqa™), a Novel Treatment for Excessive Facial HairCurrent Medical Research and Opinion, 2001